The global High throughput screening market will grow at a CAGR of 8.0% from 2017 to 2022 to reach USD 21,911.2 million by 2022, according to the latest publication from Meticulous Research®. The global high throughput screening market is primarily driven by the increasing adoption of innovative approaches in pharmaceutical and biotechnology companies, rising investment by private equity firms and venture capitalists, increasing government funding for various R&D activities, growing healthcare spending, and various technological advancements in this field. Further, growing research in toxicology and stem cell research provide significant opportunities in this market. However, high cost for HTS, intricacy in the field of assay development, and government regulations for drug development obstructs the growth of this market to some extent.
The global high throughput screening market is mainly segmented by product & service (Consumables & Reagents, Instruments, Software & Services), by technology (Cell-based Assay, Ultra High Throughput Screening, Label-Free Technology, Lab On A Chip), by application (Stem Cell Research, Toxicology Assessment, Primary Screening, Target Identification), by end user (Pharmaceuticals and Biotechnology Industry, Academics and Research Institutes, Contract Research Organizations, and others), and by geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Based on products, the consumables & reagents segment dominated the overall market in 2016 and is also estimated to continue its dominance over the forecast period, owing to the availability of a wide variety of reagents, rising demand for consumables & reagents with increasing adoption of HTS in drug discovery, and continuous launch of innovative technology-based products in the global market.
Based on technology, cell-based assay segment commanded the largest share in 2016, owing to the large adoption of cell-based platforms to gain accurate and more relevant in vivo biological information in high-throughput drug screenings for target validation and ADMET (absorption, distribution, metabolism, elimination, and toxicity) in drug discovery.
On the basis of application, target identification segment held the largest share of the global high throughput screening market in 2016, owing to the rising adoption of high-throughput products for efficient, faster, and cost-effective identification of targets in early-stage drug discovery.
Based on the end user, the pharmaceuticals & biotechnology industry dominated the high throughput screening market in 2016, owing to higher adoption of high throughput screening assay for drug discovery and development and regenerative medicine in this industry.
Geographically, North America accounted for the major share of the global high throughput screening market in 2016, followed by Europe and Asia-Pacific region. The major share of the North American region is mainly attributed to the higher spending on pharmaceutical R&D, higher adoption of advanced HTS technologies in drug discovery & development, well-established healthcare system, availability of government funding, and the presence of leading players in this region. However, Asia-Pacific region is slated to register the fastest growth during the forecast period, primarily due to rising R&D expenditure, increasing pharmaceutical research outsourcing in the region owing to lower cost advantages, increasing government funding, and improving healthcare infrastructure. In addition, significantly growing pharmaceutical industry in Asia, primarily due to huge demand for medical care from large population base with increasing incidence & prevalence of chronic disease and aging population are expected to support the growth of HTS market in the region.
The leading companies have employed various strategies to expand their product and application offerings, global footprint, and augment their market shares. The key strategies followed by most companies in the global high throughput screening market were new product launches, mergers & acquisitions, and expansions. The key players in the global high throughput screening market are MERCK KGaA, Charles River Laboratories International, Inc., AXXAM S.p.A., Thermo Fisher Scientific Inc., Danaher Corporation, PerkinElmer Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Tecan Trading AG, Aurora Biomed, Inc., and Hamilton Company.
Download sample copy of report before purchasing this report @ https://www.meticulousresearch.com/download-sample-report/cp_id=3206
Key questions answered in the report-
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123
Dental Practice Management Software Market Worth $ 3.11 Billion by 2029Read More